跳至主要内容
临床试验/NCT06306430
NCT06306430尚未招募不适用

Detection of Lipoarabinomannan in Urine, Evaluation of the STANDARDTM F TB LAM FIA and Its Impact on the Initial Diagnosis of TB

Ospedale San Raffaele1 个研究点 分布在 1 个国家目标入组 550 人开始时间: 2024年5月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
550
试验地点
1
主要终点
Evaluate the diagnostic performance of a new test based on the detection of lipoarabinomannan (LAM) antigen in human urine using immunoassay

研究概览

简要总结

Evaluation of the performance of an in vitro test, the STANDARDTM F TB LAM Ag FIA (SD BIOSENSOR, INC.) for the early diagnosis of tuberculosis (TB) infection. This test is for in vitro professional diagnostic use and intended as an aid to early diagnosis of tuberculosis infection. The test will be used according to the instructions for use (IFU).

详细描述

STANDARDTM F TB LAM Ag FIA is a fluorescent immunoassay which detects lipoarabinomannan in human urine sample. The test evaluated in this study may provide benefits for the development of non sputum-based, less invasive tuberculosis diagnostics that include easier to collect biological samples. The study can therefore be relevant for updating WHO guidelines for TB diagnosis. The results of the STANDARDTM F TB LAM Ag FIA will be interpreted according to the manufacturer´s instructions and will be compared to the results of the test performed to confirm the pulmonary TB, the extrapulmonary TB or the pulmonary NTM diagnosis (intention to treat assay). The test will be repeted at the end of the anti-TB therapy to evaluate if the test can be used as marker of treatment response. Healthy subjects without exposure or risk for TB factors will serve as a proxy for specificity; subjects with confirmed TB will serve as control group to estimate sensitivity.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inclusion criteria for PTB, PNTM and extraPTB:
  • Adult subjects with documented active pulmonary TB, pulmonary NTM or extrapulmonary TB
  • Subjects who have signed informed consent
  • Aged ≥18 years
  • Inclusion criteria for HC:
  • healthy donors who have signed informed consent
  • aged ≥ 18 years
  • no TB or NTM risk factors or exposure

排除标准

  • Exclusion criteria for PTB, PNTM and extraPTB:
  • Do not have active pulmonary TB, NTM or extrapulmonary TB
  • Do not sign the informed consent
  • Are aged < 18 years
  • Exclusion criteria for HC:
  • Have active pulmonary TB or NTM
  • Do not sign the informed consent
  • Are aged < 18 years

结局指标

主要结局

Evaluate the diagnostic performance of a new test based on the detection of lipoarabinomannan (LAM) antigen in human urine using immunoassay

时间窗: 12 months

STANDARDTM F TB LAM Ag FIA is a fluorescent immunoassay for the qualitative detection of specific antigen from mycobacterial lipoarabinomannan (LAM) in urine. The test should be used with the STANDARD F Analyzers manufactured by SD BIOSENSOR that are Europium (Eu) based fluorescent immunoassay system and have been designed for easy and reliable measuring of diverse parameters. The test result of a specimen is given either as Positive or Negative with a COI (cut off index) value. The test may provide benefits for the development of non sputum-based, less invasive tuberculosis diagnostics that include easier-collect biological samples. The results of the test will be compared to the results of the test performed to confirm the pulmonary TB, the extrapulmonary TB or the pulmonary NTM diagnosis Healthy subjects without exposure or risk for TB factors will serve as a proxy for specificity; subjects with confirmed TB will serve as control group to estimate sensitivity.

次要结局

  • Exploratory Objectives Evaluate if the test can be used as marker of treatment response (only for PTB subjects)(6 months)

研究者

发起方
Ospedale San Raffaele
申办方类型
Other
责任方
Principal Investigator
主要研究者

Daniela Maria Cirillo

head Emerging Bacterial Pathogens Unit

Ospedale San Raffaele

研究点 (1)

Loading locations...

相似试验